Book Chemotherapy Eye Evaluation | Lahalak Medical Platform

Safeguard your vision from chemotherapy side effects. Our comprehensive evaluation monitors ocular surface toxicity and lacrimal gland health, ensuring effective management of dry eye symptoms throughout your treatment journey.

Scientific name: Chemotherapy-Induced Ocular Surface Evaluation

A specialized medical evaluation monitoring the impact of chemotherapy on ocular health. It assesses lacrimal gland function and tear film stability to manage toxicity and prevent chronic irritation.

Chemotherapy-Induced Ocular Surface Evaluation - Protect Your Eyes During Chemotherapy
Service type Specialized Medical Evaluation
Duration 30-45 minutes
Fasting Fasting is not required

Included Services

  • Slit-lamp biomicroscopy
  • Schirmer's test
  • Tear Break-up Time (TBUT) assessment
  • Specialist ophthalmologist consultation

Medical Service Information

Why is this evaluation necessary?

  • Early detection of ocular surface toxicity
  • Prevention of permanent corneal scarring
  • Relief from burning, stinging, and blurred vision

Symptoms Requiring Evaluation

  • Severe dryness not responding to standard drops
  • Persistent redness and reflex tearing
  • Extreme sensitivity to light (photophobia)

Frequently Asked Questions

  • Does chemo always affect the eyes? Not always, but it is common with specific agents.
  • When should I get evaluated? Ideally before starting chemo and periodically during treatment.

Conditions & Notices

  • Bring a list of current chemotherapy medications
  • Remove contact lenses before the evaluation